Our Company is a diversified and innovation-driven enterprise specializing in the manufacturing, marketing, and global distribution of an extensive range of pharmaceutical and cosmetic products. We are committed to delivering scientifically advanced, safe, and high-quality formulations that cater to the healthcare and personal care needs of diverse consumer groups and medical communities.
Within the pharmaceutical domain, we develop and manufacture a comprehensive portfolio of therapeutic formulations, including antibiotics, anti-cold preparations, antihistamines, antidiabetic medications, cardiovascular therapies, gynecological treatments, analgesics, antifungal agents, and multivitamins. Each product is manufactured with rigorous precision, ensuring compliance with stringent quality protocols, regulatory standards, and Good Manufacturing Practices (GMP).
In the cosmetic and personal care segment, our offerings encompass a wide variety of skin care, oral care, and hair care solutions, formulated using advanced ingredients and dermatologically aligned technologies. These products are available in multiple delivery formats gels, ointments, creams, lotions, oils, and serums designed to ensure efficacy, usability, and consumer satisfaction.
Expanding beyond manufacturing, we are actively involved in the procurement and trading of specialized packaging materials and essential raw materials, thereby supporting our own operations as well as contributing to the broader pharmaceutical and cosmetic supply ecosystem.
We provide comprehensive contract manufacturing services for both pharmaceutical and cosmetic products to clients across domestic and international markets, offering end-to-end solutions marked by reliability, scalability, and strict quality assurance. Alongside this, we market our own brands, including “Glow Up”, “Regero”, and the soon-to-be-launched “Avicel” skincare line. Our products under the Glow Up brand are also accessible through prominent e-commerce platforms such as Amazon and Tata 1MG, enhancing our reach and consumer accessibility.
On the global front, we directly export our products to countries including Iraq and Yemen, with ongoing initiatives to strengthen and expand our international presence. In pursuit of entry into highly regulated markets, we recently underwent a USFDA audit for OTC products, subsequently submitting our compliance documentation. Attaining this regulatory milestone significantly elevates our capacity to supply the United States market and establishes a strong foundation for expansion into additional global territories.
Through innovation-driven operations, regulatory excellence, and a commitment to quality, our Company continues to build a strong and trusted presence in both the pharmaceutical and cosmetic industries.